Background: Acute lymphoblastic leukemia (ALL) and its treatment are often implicated in adversely affecting bone health. Conflicting reports in the literature and a paucity of studies from the developing world prompted us to study bone mineral density (BMD) in childhood ALL survivors.
INTRODUCTION
Successful treatment of childhood acute lymphoblastic leukemia (ALL) has led to an increasing population of survivors. This has made surveillance of late effects an important element in their follow-up. 1 Furthermore, skeletal health is often overlooked during these evaluations. 2, 3 The majority of an individual's total skeletal mass is accumulated during childhood and adolescence. 4 Therefore, a serious disease like ALL occurring during this period is likely to predispose one to low bone mineral density (BMD) through various mechanisms including Abbreviations: ALL, acute lymphoblastic leukemia; BMD, bone mineral density; BMI, body mass index; DXA, dual energy x-ray absorptiometry; ECLIA, electrochemiluminescence immunoassay; HA, height-adjusted; IGF-1, insulin-like growth factor-1; LS, lumbar spine; NCI, National Cancer Institute; PAQ score, physical activity score; WB, whole body poor nutrition, decreased physical activity and negative effects of the disease and its treatment. 5 Most of the published literature on BMD in ALL survivors has been reported from the developed world. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] These reports greatly support the observation of BMD deficit in adult ALL survivors, [6] [7] [8] [9] [10] [11] [12] [13] [14] although two recent studies report no such deleterious impact. 15, 16 There is a paucity of data from the developing world, where the prevalence of co-morbid nutritional deficiencies is likely to be high. This prompted us to evaluate the prevalence of low BMD and its risk factors (demographic, disease-, treatment-and lifestylerelated factors such as diet and exercise) in a cohort of childhood ALL survivors in whom the time period since cessation of therapy was at least 2 years. These parameters were also observed in age-and sex-matched siblings who served as controls for the purpose of this study.
METHODS

Participants
All patients were treated in a comprehensive care cancer center that caters to low-and middle-income patients from North India. In this cross-sectional observational study, survivors of childhood ALL who were ≤18 years of age at diagnosis and treated between 1996 and 2008 and in first complete remission were identified from the hospital medical records and included for analysis. The time period since cessation of therapy was at least 2 years in all of these patients. Patients with a history of relapse, bone marrow transplantation or second malignancy were excluded. The eligible patients were contacted by phone for the study and those who consented were scheduled for an outpatient department visit. The cases were compared against healthy control siblings who were matched for age (±1 year) and sex. A written informed consent was obtained from parents (in case of patients <18 years of age) or subjects (patients ≥18 years of age) as appropriate. The study protocol was approved by the institutional ethics committee.
Data collection
Data regarding the demographic profile, disease characteristics and treatment details were retrieved from the institutional medical records. Demographic data included the age at diagnosis, gender and date of diagnosis. Information pertaining to the immunophenotype, National Cancer Institute (NCI) risk category and the chemotherapy protocol was recorded. The cumulative doses of steroids (in prednisone equivalents, 1 mg prednisolone = 0.15 mg dexamethasone) and methotrexate, and the details of cranial or testicular irradiation were ascertained. Anthropometry and Tanner staging for pubertal maturity were determined at the time of analysis. 17 Weight was measured to the nearest 0.1 kg using a digital weighing scale. Height was measured to the nearest 0.1 cm using a wall-mounted stadiometer. Body mass index (BMI) was calculated using the formula: Weight (kg)/Height (m). 2 World Health Organization (WHO) growth charts were used for interpretation of anthropometry. 18 Overweight was defined as BMI +1 to +2 SD, obese as BMI > +2 SD and thin as BMI < −2 SD for age. Short stature was defined as height < −2 SD. Testicular volume was determined using Prader's orchidometer. An x-ray of the left hand was done for estimating the bone age using the Tanner Whitehouse 3 method. 19 Normal bone age was defined as bone age within ±2 years of chronological age (equivalent to ±2 SD).
Bone mineral density evaluation
BMD was assessed by dual energy x-ray absorptiometry (DXA) using Hologic Explorer (S/N 91531) software version 13.3:3. The measurement sites were L1 to L4 lumbar spine (LS) and whole body (WB), as recommended by the International Society of Clinical Densitometry. 20 The parameters measured were bone mineral content in grams and areal BMD in g/cm 2 . Areal BMD was transformed into Z-scores (standard deviation scores) by the machine software using the ageand sex-specific Asian reference data provided by the manufacturer.
Height-adjusted (HA) BMD Z-score values were generated using an online calculator available on www.bmdcspublic.com to avoid the confounding effect of height on areal BMD. 21 Low BMD was defined as a Z-score value ≤ 2. 20
Biochemical and hormonal analysis
The biochemical analysis included serum total calcium and alkaline phosphatase measured by colorimetric assay, phosphorus by the molybdate-UV method and ionized calcium by direct ion-specific electrode assay. Total protein and albumin were also measured to calculate corrected calcium in hypoproteinemic children. Serum 25-hydroxyvitamin D and parathormone levels were determined using electrochemiluminescence immunoassay (ECLIA). All blood tests were performed in both cases and controls. In addition, cases underwent hormonal analysis which included serum follicle stimulating hormone, luteinizing hormone, testosterone/estradiol, insulin-like growth factor-1 (IGF-1), thyroid stimulating hormone and T4 levels by ECLIA.
All blood samples were collected after fasting overnight, between 8 am and 10 am, without venostasis for accurate measurement.
Calcium intake and physical activity measurement
Information on average daily calcium intake was recorded using a semi-quantitative food frequency questionnaire validated for Indian patients. 22, 23 Subjects were interviewed regarding the average frequency of intake of various calcium-rich foods on a 6-point scale ranging from daily, alternate day, weekly, fortnightly, monthly to never consumed. Daily calcium intake was computed from this data. Physical activity was assessed using a validated questionnaire, "Physical activity questionnaire for older children (PAQ-C) and adolescents (PAQ-A)." 24 This 7-day recall questionnaire measures general moderate to vigorous physical activity levels and provides an average physical activity score (PAQ score) derived from 9 items, each scored on a 5-point scale with 1 indicating the lowest physical activity score and 5 indicating the highest score.
Statistics
To summarize the population's demographic, disease and treatment profile, descriptive statistics was used with mean or median as appropriate. The categorical variables were compared between cases and controls using 2 /Fisher's exact test. The comparability of BMD data between cases and controls was assessed by smoothed kernel density plots. The relationship of mean BMD Z-scores of cases with known predictors of low BMD was assessed using appropriate tests of significance (Mann-Whitney U and Student's t tests were used for nonnormally and normally distributed variables, respectively). All statistical analysis was performed using SPSS software (version 22; SPSS, Inc., Chicago, IL). The P value <0.05 was considered as statistically significant.
F I G U R E 1
Flowchart of participants from eligible parent population. ALL, acute lymphoblastic leukemia; CR, complete remission.
RESULTS
Participants
Among the 122 eligible ALL survivors identified for the study, 65 patients consented for participation (Fig. 1) . The demographic, disease, protocol 25, 26 and treatment details of the participants are summarized in Table 1 and were similar to 122 eligible patients (Supplementary Table S1 ). The controls constituted 50 age-and sex-matched healthy siblings. The median age of the healthy children was 15 years (range, 7.9-27 years; P = 0.905) and 11 of 50 (22%) were females (P = 0.486).
Anthropometry and bone mineral density
The anthropometric data and mean bone density parameters of cases and controls are reported in Table 2 . The BMI of cases was significantly higher than that of the controls (P = 0.035). Also, the proportion of obese or overweight survivors (21/65) was significantly higher than that observed among the control group (6/50), P = 0.012. Three cases (two familial; one pathological) and two controls (both familial) had short stature. Low HA-LS BMD was prevalent in 8 of 65 (12.3%) cases and 5 of 50 (10%) controls (P = 0.856). The corresponding values for WB were 4/65 (6.1%) and 4/50 (8%) among the cases and controls, respectively (P = 0.674). The mean values of DXA parameters were lower in survivors, though not statistically significant ( Table 2 ). The history of fracture was also not different among the cases (9/65, 13.8%) and controls (7/50, 14%, P = 1.0). Fig. S1 ) showed that the areas covered by the smoothed lines were similar in cases and controls, implying similarity in the BMD Z-scores among the groups.
Kernel density plots (Supplementary
Calcium intake and physical activity
The mean daily calcium intake in cases and controls was 886.9 ± 392.3 mg and 851.7 ± 356.7 mg, respectively (P = 0.621). It was below the Indian recommended intake 27 
Biochemical and hormonal analysis
All biochemical parameters studied were similar in cases and controls ( 
Effect of predictors of bone mineral density
The relation of predictors of low BMD with mean BMD Z-scores is shown in Table 4 . BMI ≥ +1 SD was shown to have a significant protective effect on BMD across all Z-score categories. A trend towards higher mean BMD Z-scores was observed among patients with calcium intake ≥800 mg/day (WB, P = 0.
018). Patients with vitamin D level >25
nmol/L had significantly better mean HA Z-score WB (P = 0.046).
DISCUSSION
In this study, BMD was used as a surrogate marker to evaluate the skeletal health of childhood ALL survivors. Most published studies are from the developed world and report data from an ethnically and nutritionally different population. 31, 32 This study is an attempt to address this deficit by comprehensively evaluating survivors treated with contemporary ALL therapy in a developing country. The comparison with BMI, body mass index; Cum, cumulative; HA, height adjusted; MTX, methotrexate; PAQ, physical activity score; PE, prednisone equivalent; RT, radiation; SMR, sexual maturity rating. a P < 0.05.
TA B L E 4 Univariable analysis of various factors associated with low BMD Z-scores
age-and sex-matched sibling controls offered a unique opportunity to understand the impact of the disease and its treatment on BMD without the confounding effects of possible genetic, environmental, psychosocial and economic factors. Detailed analysis of the biochemical and hormonal profile, physical activity and dietary calcium intake makes our study one of the first to evaluate the impact of these factors on skeletal health. We found that the prevalence and severity of low HA-LS and WB BMD was similar among the ALL survivors and controls.
The evaluation of risk factors for low BMD showed no variation in BMD hypothesized that abnormalities in bone mineralization and BMD do occur due to leukemia and its treatment, which subsequently recover.
These findings are supported by our data, where BMD Z-scores in patients at 2 or more years after completion of therapy were comparable to the age-matched sibling controls. However, in the absence of longitudinal data, it is not possible to comment upon the recovery of BMD after cessation of therapy.
Various studies 6, 9, 11, [36] [37] [38] in the literature have demonstrated the negative impact of cranial irradiation on BMD and that this association is more consistent with higher doses (24 Gy). 7 However, we did not observe any difference in the mean BMD Z-scores of patients treated with or without cranial irradiation. This may be attributed to the administration of lower doses (12.6 Gy) of prophylactic cranial irradiation to the majority of the study patients. Unlike previously published reports, there was no observable impact of cumulative doses of steroids or methotrexate in the present analysis. [39] [40] [41] Mandel et al. 16 reported BMD to be influenced by very high cumulative doses of methotrexate (>40 g/m 2 ) and steroids (>9 g/m 2 ). These doses are considerably higher than those administered to our patients. Hence, our study supports the finding of preservation of BMD by restriction of cranial irradiation and doses of chemotherapeutic agents known to influence BMD.
The high incidence of hypovitaminosis D (93.6%) and inadequate dietary calcium (38.4%) observed among our survivors was a cause of concern. This was particularly due to their association with low BMD, as also reported by others, 9, 12, 13, 42, 43 as well as its long-term influence on bone health and early occurrence of osteopenia in later life. 44 Similar deficiencies reported in a large cohort of healthy school children from North India by Marwaha et al. 45 reflect a high prevalence in the general population, possibly because of the dietary patterns (low in calcium and high in fiber and phytates).
A low physical activity score (PAQ ≤ 2.5) was more frequently observed among the survivors as also reported by others. 7 However, the effect of physical activity on BMD could not be elucidated in the present analysis unlike other published reports. 12, 14, 46 This may be because of the limitations inherent in the questionnaire. 24 Nevertheless, it seems wise to emphasize the importance of regular physical activity, and adequate dietary intake of vitamin D and calcium consistently during follow-up.
Owing to the small proportion of patients with endocrinologic dysfunction, our study had limited statistical power to evaluate the impact of endocrinopathy on BMD. Overweight and obese patients had better BMD Z-scores which may either reflect the protective effect of high BMI on BMD or may be a measurement artifact due to attenuation of xray beams by soft tissue. 33, 47, 48 The higher incidence of obesity among cases (compared to controls) may also have contributed to the lack of difference observed in BMD between the two groups.
It is important that results from various BMD studies be interpreted in the light of BMD tools used, ethnicity of the population, treatment protocol, duration since cessation of therapy and nutritional and vitamin D status.
Our study has many strengths. It provides an important insight into the profile of BMD along with its predictors in survivors of childhood ALL from the developing world. We attempted to evaluate most of the reported risk factors for low BMD. A comparison with sibling controls made results more meaningful. We used DXA scanning, which is a standard, well-understood method of studying bone density, avoiding the excess of radiation exposure of quantitative CT, which has arguably been regarded as the most accurate method for estimating BMD. Moreover, we calculated corresponding height-adjusted Zscores to avoid the effect of height on areal BMD, to get more accurate estimates. BMD was measured in both lumbar spine and whole body to determine the density of both trabecular and cortical bone which are affected disproportionately by the potential etiologies of low bone mass.
The main limitation of our study is that the study cohort constituted a heterogeneous population in terms of wide variation in age at diagnosis, age at BMD analysis, and duration since the cessation of therapy.
The absence of Indian reference values for BMD compounded these difficulties. Although Indian Lunar DXA values are available, these cannot be applied to the data obtained from a Hologic machine, as in the present analysis. 49 Moreover, the normative Asian BMD values used by the Hologic DXA machine may not be truly representative of our population, thereby, leading to an overestimation of the prevalence of low BMD Z-scores in both cases and controls.
To conclude, in this study, there was no significant adverse impact of the disease or its treatment, including cranial irradiation on BMD in ALL survivors. This finding was reassuring considering that the study population was from a developing country. As inadequate calcium intake and low vitamin D levels were associated with low BMD, further studies are recommended targeting these modifiable factors to optimize the bone health. There is also a strong need to establish ethnicity-specific norms of BMD parameters for more appropriate comparisons.
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